The latest statistics that were published seem to indicate that the AstraZeneca boosters are not sustainable considering the long term implications. The plans to make the people follow a half year cycle with the vaccines was simply unrealistic, according to AstraZeneca vaccine creator.
- MAJOR PEER REVIEWED STUDY: Moderna Vaccine Increases Myocarditis Risk By 44 Times In Young Adults
- MUST READ: High Level International Bankers Simulate The Collapse Of Global Financial System
- BIG STORY: Wuhan Lab Isolated Monkeypox Strain In 2020
- EXPLOSIVE: Ukraine Biolabs Used Fever Carrying Mosquitoes To Spark Dengue Pandemic In Cuba
The person behind the Oxford/AstraZeneca COVID-19 vaccine branded as Covishield in India, has suggested that plans to deliver booster doses twice a year are “not sustainable” and that any supply of the vaccine beyond the third dosage should be discontinued until more evidence of its need emerges.
Professor Sir Andrew Pollard, director of the Oxford Vaccine Group and chair of Britain’s Joint Committee on Vaccination and Immunization (JCVI), said in an interview with The Telegraph on Monday that the COVID shot implementation must be limited to “target the vulnerable” instead of giving everyone booster shots.
Furthermore, the well-known scientist stated that the omicron strain proves that draconian lockdown measures are no longer necessary, noting that “at some point, society has to open up.” He added that “[w]hen we do open, there will be a period with a bump in infections, which is why winter is probably not the best time. But that’s a decision for the policy makers, not the scientists.”
The JCVI is anticipated to assess the necessity for a fourth batch of injections, based on data from the United Kingdom’s Health Security Agency, which shows that immunity from the third dosage wears out after about ten weeks.
Subscribe to GreatGameIndia
Nevertheless, Pollard, the committee’s chair, emphasized that society cannot hope to totally eradicate infection, and that administering continuous booster doses is not a practical solution.
Although being a big proponent of vaccinations and having played a vital part in the creation of AstraZeneca’s COVID vaccine, Pollard highlighted that “we can’t vaccinate the planet every four to six months. It’s not sustainable or affordable.”
“[If] your goal is to stop all infections … that is wrong,” the scientist added, emphasizing that when it comes to the virus “the worst is absolutely behind us.” He noted that “more strong evidence is needed” before following the lead of locations like Israel, which has approved the use of a fourth booster dose.
However, one of the most vaccinated nation Israel may switch to the policy of herd immunity to be achieved through mass infection as the vaccines have failed to curb the rising cases of COVID-19 Omicron variant.
Pollard is not participating in JCVI deliberations about the novel coronavirus because of his role in designing the AstraZeneca shot for COVID-19.
In the United Kingdom, the AstraZeneca vaccine is by far the most prevalent, contributing for little under half of all first and second doses given. Despite being closely trailed by Pfizer’s mRNA vaccine, which amounts for about 47% of all doses given, the AstraZeneca vaccine has garnered the majority of Yellow Card reports (adverse event reports).
The Oxford-developed vaccine has generated 240,065 reports from people who have had 850,893 unique adverse events, accounting for more than 58 percent of all COVID-related concerns in the UK.
Worries were expressed in March concerning the risk of serious blood clots developing after receiving the AstraZeneca shot, such as deep vein thrombosis (DVT) and thrombocytopenia (low platelet counts). The issue was so serious at the time that nine nations briefly withdrew their backing for the shot.
Earlier, German scientists found the exact 2 step process how the COVID-19 vaccine causes blood clots in recipients. They describe a series of events that has to happen in the body before the vaccines create these large clots.
German scientists have found out how the broken parts of Johnson & Johnson and AstraZeneca COVID-19 vaccines branded as Covishield in India mutate to trigger blood clots in recipients.
The US CDC and FDA lifted their recommended pause on use of Johnson & Johnson’s coronavirus vaccine with a condition that it will now include a safety label warning that its vaccine comes with blood clot risks.
COVID vaccines are “irreversible and potentially permanently damaging,” says Dr. Robert Malone, who explains why 16,000 physicians and medical scientists around the world signed a declaration publicly declaring healthy children should not be vaccinated for COVID-19.